Jeffrey Jones, MD

Ohio state UniversityColumbus, Ohio - 43210 |
- CLINICAL TRIALS 1
- CONDITIONS3
- INTERVENTIONS2
- SINCE2010

Multi-center Trial of Revlimid and Rituximab for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
August 2010 - June 2014
Leukemia
Leukemia, Lymphocytic, Chronic, B-Cell
Leukemia, Lymphoid
Revlimid, Rituximab
Relapsed Or Refractory Cll. Lenalidomide And Rituximab



